Sulla morte incurabile

Death is incurable. It precedes, transcends and overcomes any possibility of cure. Medicine cures, but leaves man's fundamental event, his death, without cure. After a lifetime of treatment, everyone dies, even those who have used all kinds of treatments, so as not to die. Molecules, surgery, nuclear medicine, technology is not and will never be adequate for death. What can be appropriate for death? Not the escape, but the awareness of its existence, in every minute of the short earthly passage. But how? Man has always used artistic expression, not science, as a way of seeing death. Literature, cinema, theater are human inventions that go through death, and in this article we expose some artistic productions that cure our existence from the "Incurable".

From the respective expert viewpoints of the ANM specialty editors

Although it may not be well known, the Annals of Nuclear Medicine (ANM) Editorial Committee includes one specialty editor of nuclear medicine physics, one of nuclear medicine technology, one of molecular imaging, and two of radiopharmacology. In addition, a statistics editor and a language editor are also on the committee. Manuscripts submitted to ANM can be peer-reviewed by such specialty editors similar to those submitted to highly ranked journals, which is a great pride and joy to us. To offer our readers a condensed global view on the high-quality research work in the field of nuclear medicine, we have published a mini-review article every year under the joint authorship of the ANM associate editors since 2016. This is our fourth serial review article written by the ANM specialty editors from their respective expert viewpoints.

Prospects for Implementing of Technologies of Nuclear Medicine in the FMBA of Russia

The article is devoted to development prospects of nuclear medicine in the Russian Federation. One of the first to provide nuclear medicine in Soviet Union was A.I. Burnasyan. He headed the 3d Directorate General of Ministry of Health (the FMBA of Russia at present). The Institute of Biophysics and the Institute of Medical Radiology (Obninsk), was established in the 50s – 60s of the 20th century, laid the foundation for nuclear medicine and developed it. With their efforts, nuclear medicine in USSR has become the world leader. However, in the 1980s – 1990s, there was a serious lag in this area due to radiophobia that arose after the Chernobyl accident, as well as the collapse of the USSR and the severe economic crisis, overcoming which in the beginning of the 21st century made it possible to pay considerable attention to nuclear medicine. Today the FMBA of Russia leads in the development and application of nuclear medicine technology. In the departments of the FMBA of Russia – the Siberian Research and Clinical Center (Krasnoyarsk) and Northern Medical Clinical Center N.A. Semashko (Arkhangelsk) – carries out high-tech diagnostics and treatment of cancer, neurological and cardiac diseases. Currently, in Dimitrovgrad city, the creation of the Federal High-Tech Center for Medical Radiology of the FMBA of Russia (FHCMR, FMBA of Russia) under the state program “Establishment of Federal Centers of Medical Radiological Technologies” is being completed. FHCMR, FMBA of Russia will provide high-tech medical care to the assigned contingent of the FMBA of Russia and the adult population of the Central, Volga, North-West federal districts. In the article noted the need for training specialists in the nuclear medicine. Training of specialists is already being conducted at the Training and Education Center of the Federal Siberian Research and Clinical Center of the FMBA of Russia. An important aspect of the introduction of nuclear medicine technologies and the operation of such centers are issues of legal regulation. The article pays attention to the licensing of nuclear medicine objects in accordance with the requirements of the Federal Law No. 170-FZ of November 21, 1995 “On the Use of Atomic Energy”. The tasks that need to be addressed for the development of nuclear medicine technologies are formulated, including through the implementation of the public-private partnership mechanism, as well as by expanding international cooperation with the EAEU member states.